MED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs
Rachel Ruoff(New York University), Michael J. Garabedian(New York University)
Cited by 4
Related Papers
Statins Promote the Regression of Atherosclerosis via Activation of the CCR7-Dependent Emigration Pathway in Macrophages
|PLoS ONE|2011|149
MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen
|PLoS Genetics|2021|28
A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer
|Molecular Cancer Therapeutics|2023|4
MED19 alters AR occupancy and gene expression in prostate cancer cells, driving MAOA expression and growth under low androgen
|bioRxiv (Cold Spring Harbor Laboratory)|2019|2